olivLaw · US equity research
INNOVATE Corp. VATE
Fabricated Structural Metal Products · SIC 3440 · Vertical: Fabricated metal products (SIC 344x)
INNOVATE Corp. is a holding company whose main revenue comes from DBM Global, a structural steel construction group, alongside life sciences and broadcasting businesses. In 2026 the company is reshaping its portfolio: a sale of DBMG and a controlling stake in Broadcasting could change the business profoundly, and the company has stated there is substantial doubt about its going concern. Revenue in the second quarter of 2026 rose 74.2%.
At the close of 04 Nov 2026, INNOVATE Corp. (VATE) stock was 5.43 USD (−3.21% on the day), with market capitalisation 74.1 m USD, dividend yield 0.00%, beta 1.56, 52-week range 3.98–20.06 USD. Latest reported quarter (Q2 2026): revenue of 421.6 m USD (+74.2% YoY), net income of 10.7 m USD, diluted EPS 0.71 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 33.5
- weak (30–45)
- Bollinger (20, 2)
- 4.93 – 7.08
- in the lower half of the band · %B 0.23 · band width 35.9%
- SMA 50 / 200
- 6.89 / 8.94
- downtrend (price < SMA50 < SMA200)
- MACD (12, 26, 9)
- -0.45 / -0.46
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | −27.0% | −1.1% | −25.9 pp | — |
| 3 months | −28.2% | −0.5% | −27.7 pp | — |
| 6 months | −56.2% | +4.4% | −60.6 pp | — |
| Year to date | +20.1% | +12.3% | +7.8 pp | — |
| 1 year | −3.0% | +13.5% | −16.6 pp | +1.9% |
| 3 years | −54.4% | +76.4% | −130.8 pp | +85.2% |
| 5 years | −88.1% | +63.7% | −151.7 pp | — |
Price returns, dividends excluded.
Quarterly results
Latest quarter: Q2 2026 · 30 Jun 2026
Quarterly margins
Quarterly statements · USD
| Fiscal year | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 242.2 m | 236.6 m | 274.2 m | 242.0 m | 347.1 m | 382.7 m | 364.8 m | 421.6 m |
| Cost of revenue | 194.0 m | 190.2 m | 228.7 m | 196.4 m | 297.4 m | 323.8 m | 311.3 m | 342.1 m |
| Gross profit | 48.2 m | 46.4 m | 45.5 m | 45.6 m | 49.7 m | 58.9 m | 53.5 m | 79.5 m |
| SG&A | 37.4 m | 40.4 m | 37.8 m | 35.1 m | 39.6 m | 40.6 m | 39.4 m | 41.5 m |
| Operating income | 5.9 m | 2.5 m | 3.4 m | 4.9 m | 6.1 m | 14.3 m | 10.0 m | 34.5 m |
| Depreciation & amortisation | 4.4 m | 8.1 m | 7.9 m | 4.4 m | 4.3 m | 7.6 m | 7.4 m | 3.5 m |
| Interest expense | 21.2 m | 19.6 m | 20.2 m | 21.4 m | 23.4 m | 24.0 m | 24.5 m | 27.6 m |
| Pre-tax income | -13.1 m | -14.9 m | -18.7 m | -16.8 m | -16.7 m | -9.3 m | -14.2 m | 25.5 m |
| Income tax | 3.1 m | 2.4 m | 7.1 m | 4.2 m | -7.1 m | -1.7 m | 2.9 m | 13.1 m |
| Net income | -15.0 m | -16.6 m | -24.5 m | -19.8 m | -8.9 m | -7.4 m | -16.8 m | 10.7 m |
| Diluted EPS | -1.18 | -1.28 ≈ | -1.89 | -1.67 | -0.71 | -0.55 ≈ | -1.29 | 0.71 |
| Operating cash flow | -28.4 m ≈ | 41.4 m | -14.1 m | 40.4 m ≈ | 19.2 m ≈ | 101.1 m | 45.5 m | -24.6 m ≈ |
| Capex | 3.1 m | 7.2 m | 4.7 m | -4.4 m ≈ | 200.0 k ≈ | 0 | 200.0 k | 100.0 k ≈ |
| Dividends paid | 300.0 k ≈ | 300.0 k | 300.0 k | 800.0 k ≈ | 400.0 k ≈ | 700.0 k | 400.0 k | 300.0 k ≈ |
≈ derived quarter (cumulative difference / share-days average)
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Fiscal years
| Fiscal year | 2018 | ⚠ 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.0 bn | 1.1 bn | 716.9 m | 1.2 bn | 1.6 bn | 1.4 bn | 1.1 bn | 1.2 bn |
| Revenue YoY | +21.0% | — | −33.4% | +68.1% | +35.9% | −13.1% | −22.2% | +12.5% |
| Net income | 162.0 m | -31.5 m | -92.0 m | -227.5 m | -35.9 m | -35.2 m | -34.6 m | -60.6 m |
| Net income YoY | unavailable | — | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable |
| Diluted EPS | unavailable | -0.70 | -1.88 | -2.98 | -0.53 | -4.81 | -3.08 | -4.84 |
| Diluted EPS YoY | unavailable | — | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable |
| net % | 8.2% | -2.9% | -12.8% | -18.9% | -2.2% | -2.5% | -3.1% | -4.9% |
| Free cash flow | 301.7 m | 86.0 m | 23.3 m | 2.9 m | -30.2 m | 8.1 m | -9.9 m | 146.1 m |
The series breaks before 2019: earlier years come from the original reports of the issuer of that time, later years from a subsequent filing that restated the perimeter (a separation, discontinued operations). The year-on-year change across the break is not shown.
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2025 · 31 Dec 2025
- Cash
- 108.2 m USD
- Financial debt
- 518.6 m USD
- Net debt
- 410.4 m USD
- Equity
- -226.2 m USD
- Total assets
- 950.1 m USD
- Debt / equity
- unavailable
- Current ratio
- 0.44x
- ROE
- unavailable
- ROA
- -6.6%
- FCF margin
- 11.7%
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Revenue | 716.9 m | 1.2 bn | 1.6 bn | 1.4 bn | 1.1 bn | 1.2 bn | SEC (XBRL)· 26 Mar 2026verified |
| Cost of revenue | 588.5 m | 1.0 bn | 1.4 bn | 1.2 bn | 898.3 m | 1.0 bn | SEC (XBRL)· 26 Mar 2026verified |
| Gross profit | 128.4 m | 183.7 m | 221.4 m | 216.0 m | 208.8 m | 199.7 m | SEC (XBRL)· 26 Mar 2026verified |
| SG&A | 145.5 m | 168.3 m | 180.1 m | 168.0 m | 160.2 m | 153.1 m | SEC (XBRL)· 26 Mar 2026verified |
| Operating income | -28.3 m | -10.6 m | 13.4 m | 26.5 m | 40.0 m | 28.7 m | SEC (XBRL)· 26 Mar 2026verified |
| Depreciation & amortisation | 26.8 m | 37.6 m | 42.2 m | 36.0 m | 32.9 m | 30.4 m | SEC (XBRL)· 26 Mar 2026verified |
| EBITDA | -1.5 m ≈ | 27.0 m ≈ | 55.6 m ≈ | 62.5 m ≈ | 72.9 m ≈ | 59.1 m ≈ | SEC (XBRL)· 26 Mar 2026derived |
| Interest expense | 74.8 m | 59.1 m | 52.0 m | 68.2 m | 74.5 m | 89.0 m | SEC (XBRL)· 26 Mar 2026verified |
| Pre-tax income | -46.7 m | -80.7 m | -41.1 m | -34.4 m | -33.4 m | -61.5 m | SEC (XBRL)· 26 Mar 2026verified |
| Income tax | 7.0 m | 5.6 m | 900.0 k | 4.5 m | 6.3 m | 2.5 m | SEC (XBRL)· 26 Mar 2026verified |
| Net income | -92.0 m | -227.5 m | -35.9 m | -35.2 m | -34.6 m | -60.6 m | SEC (XBRL)· 26 Mar 2026verified |
| Diluted EPS | -1.88 | -2.98 | -0.53 | -4.81 | -3.08 | -4.84 | SEC (XBRL)· 26 Mar 2026verified |
| Weighted average diluted shares | 50.3 m | 77.1 m | 77.5 m | 7.8 m | 10.7 m | 13.2 m | SEC (XBRL)· 26 Mar 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating income + Depreciation & amortisation.
Balance sheet · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Cash | 43.8 m | 45.5 m | 80.4 m | 80.8 m | 41.8 m | 108.2 m | SEC (XBRL)· 06 Aug 2026verified |
| Receivables | 134.7 m | 247.1 m | 254.9 m | 278.4 m | 194.0 m | 239.4 m | SEC (XBRL)· 06 Aug 2026verified |
| Inventories | 9.9 m | 17.0 m | 18.9 m | 22.4 m | 20.8 m | 16.0 m | SEC (XBRL)· 26 Mar 2026verified |
| Current assets | 6.2 bn | 442.6 m | 536.4 m | 517.9 m | 390.9 m | 451.4 m | SEC (XBRL)· 06 Aug 2026verified |
| Goodwill | 111.0 m | 127.4 m | 127.1 m | 127.1 m | 126.7 m | 105.6 m | SEC (XBRL)· 06 Aug 2026verified |
| Intangibles (excl. goodwill) | 172.1 m | 208.4 m | 190.1 m | 178.9 m | 172.4 m | 47.3 m | SEC (XBRL)· 06 Aug 2026verified |
| Total assets | 6.7 bn | 1.1 bn | 1.2 bn | 1.0 bn | 891.1 m | 950.1 m | SEC (XBRL)· 26 Mar 2026verified |
| Short-term debt | 433.6 m | 69.5 m | 30.6 m | 30.5 m | 162.2 m | 518.6 m | SEC (XBRL)· 06 Aug 2026verified |
| Current liabilities | 5.9 bn | 439.5 m | 417.2 m | 413.8 m | 483.0 m | 1.0 bn | SEC (XBRL)· 26 Mar 2026verified |
| Total liabilities | 6.1 bn | 1.1 bn | 1.2 bn | 1.2 bn | 1.0 bn | 1.2 bn | SEC (XBRL)· 26 Mar 2026verified |
| Equity | 600.2 m | -56.2 m | -90.6 m | -151.7 m | -159.3 m | -226.2 m | SEC (XBRL)· 26 Mar 2026verified |
Cash flow · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 41.1 m | 27.0 m | -9.5 m | 26.5 m | 9.1 m | 146.6 m | SEC (XBRL)· 26 Mar 2026verified |
| Capex | 17.8 m | 24.1 m | 20.7 m | 18.4 m | 19.0 m | 500.0 k | SEC (XBRL)· 26 Mar 2026verified |
| Free cash flow | 23.3 m ≈ | 2.9 m ≈ | -30.2 m ≈ | 8.1 m ≈ | -9.9 m ≈ | 146.1 m ≈ | SEC (XBRL)· 26 Mar 2026derived |
| Investing cash flow | 162.1 m | -223.2 m | -22.5 m | 39.1 m | -13.9 m | -22.6 m | SEC (XBRL)· 26 Mar 2026verified |
| Financing cash flow | -204.5 m | 4.3 m | 68.1 m | -65.3 m | -26.5 m | -61.2 m | SEC (XBRL)· 26 Mar 2026verified |
| Dividends paid | — | 2.9 m | 5.2 m | 2.2 m | 1.2 m | 2.2 m | SEC (XBRL)· 26 Mar 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
Risk
Valuation
olivLaw classification
Score: 42 / 100
A scoring methodology on indicators and valuation, not investment advice.
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: 74.1 m USD
Key indicators
Coverage and freshness
Score by group
- Valuation100
- Balance sheet0
- Quality38
- Growth0
- Returns61
Estimated value range
The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 44.62 – 856.69 USD.
Valuation assumptions are editorial choices, not measured; beta is not measured.
Method ranges (USD per share)
— — Mid · ▏ Price
Valuation methods
- DCF (discounted cash flow)281.13 – 856.69 (Mid 427.24)WACC 5.5% · starting FCFF 224.3 m USD · terminal value share of EV 86%The WACC × g sensitivity gives the method's bounds; these are not probabilities.Reverse DCF: no growth between −30% and +40% justifies the price
- Peers: EV/EBITDA44.62 – 45.84 (Mid 44.82)3 companies used · median multiple 12.3x · quartiles 12.3x – 12.4xACA, GFF, VMI
- Peers: P/Eunavailable · the base of the ratio is not positive
- Dividend discount (DDM)unavailable · the base of the ratio is not positive
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Neutral profile · Score 42/100
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | unavailable | unavailable | — |
| Net margin · Quality | -1.5% | 38 (vs peers) | 10% |
| FCF conversion · Quality | unavailable | unavailable | — |
| Revenue CAGR 3Y · Growth | -8.7% | 0 (on a fixed band) | 13% |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | 5.3x | 0 (vs peers) | 16% |
| Interest coverage · Balance sheet | 0.7x | 0 (on a fixed band) | 10% |
| Current ratio · Balance sheet | 0.4x | 0 (on a fixed band) | 6% |
| P/E (TTM) · Valuation | unavailable | unavailable | — |
| EV/EBITDA · Valuation | 6.2x | 100 (vs peers) | 16% |
| FCF yield · Valuation | 189.9% | 100 (on a fixed band) | 13% |
| Shareholder yield (distributions) · Returns | 2.4% | 35 (on a fixed band) | 10% |
| Payout ratio (FCF) · Returns | 1.3% | 100 (on a fixed band) | 6% |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet0/100 · 3/3 factors with a value
- Growth· partial0/100 · 1/2 factors with a value
- Quality· partial38/100 · 1/3 factors with a value
- Returns61/100 · 2/2 factors with a value
- Valuation100/100 · 2/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
INNOVATE CORP. (VATE). Latest full fiscal year: 2025; data up to 2026-06-30.
Figures computed from the financial statements: revenue 1.2 bn USD in 2025; YoY growth 12.5%; net margin -1.5%; net debt/EBITDA 5.3x.
The estimated value range is 162.87–451.26 USD per share (median of 2 methods, agreement: low); assumptions are illustrative. Against the central value of 236.03 USD, the price of 5.43 USD leaves a potential of 4,246.8% (value / price − 1) and a margin of safety of 97.7% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
olivLaw score 42/100, methodological classification: neutral profile (score, margin of safety and method agreement together; not a judgement of the right price). Groups assessed only in part: growth, quality. Not investment advice.
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- EV/EBITDA: 6.2x
- FCF yield: 189.9%
- Payout ratio (FCF): 1.3%
- The price is below the estimated value range
What contradicts it
- Revenue CAGR 3Y: -8.7%
- Net debt / EBITDA: 5.3x
- Interest coverage: 0.7x
- Current ratio: 0.4x
- The valuation methods diverge
Not assessed (insufficient data or a ratio without meaning): ROIC, FCF conversion, EPS CAGR 3Y, P/E (TTM).
Versus the vertical median
Fabricated metal products (SIC 344x) · same industry group (3-digit SIC) · compared with 9 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| VMIValmont Industries, Inc. | 8.1 bn | 15.9 | 30.8% | 12.1% | +0.7% | +2% / +92% |
| ACAArcosa, Inc. | 7.3 bn | 14.9 | 17.9% | 17.9% | +12.2% | +46% / +116% |
| GFFGriffon Corporation | 4.9 bn | 27.4 | 185.4% | 6.5% | −3.9% | +43% / +131% |
| PRLBProto Labs, Inc. | 1.6 bn | 46.6 | 5.1% | 6.0% | +6.4% | +31% / +84% |
| SMRNUSCALE POWER Corp | 1.2 bn | — | -30.2% | -3,888.7% | −15.0% | −74% / +85% |
| JBIJanus International Group, Inc. | 682.2 m | 20.7 | 6.0% | 3.7% | unavailable | −19% / −53% |
| IMSRTerrestrial Energy Inc. | 304.0 m | — | -36.8% | — | unavailable | −70% / unavailable |
| VATEInnovate Corp. | 74.1 m | — | — | -1.5% | +12.5% | −3% / −54% |
| TPCSTechprecision Corp | 53.6 m | — | -15.4% | -3.7% | −7.0% | +17% / −12% |
| MTENMingteng International Corporation Inc. | 8.4 m | — | -11.7% | -15.3% | +15.3% | −100% / unavailable |
1- and 3-year price returns: for VATE from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (USD)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
| 3 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
| 5 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
In brief
INNOVATE Corp. is a holding company whose main revenue comes from DBM Global, a structural steel construction group, alongside life sciences and broadcasting businesses. In 2026 the company is reshaping its portfolio: a sale of DBMG and a controlling stake in Broadcasting could change the business profoundly, and the company has stated there is substantial doubt about its going concern 12. Revenue in the second quarter of 2026 rose 74.2% 3.
SWOT
Strengths
- A solid contract portfolio in the main segment, with growing backlog and in-house fabrication and erection capacity.
- Recognised capabilities in complex design services and BIM modelling that can attract projects with better margins.
- Second quarter 2026 results showed strong revenue and margin growth in the Infrastructure segment.
Weaknesses
- Significant debt and near-term maturities that limit financial flexibility.
- Dependence on distributions from subsidiaries to service debt, which contracts and law can restrict.
- Substantial doubt about the company's ability to continue as a going concern, as stated in the annual report.
Opportunities
- Sale of DBMG or of a controlling stake in Broadcasting could reduce debt and simplify the structure.
- Rising demand for AI infrastructure and advanced manufacturing could support backlog.
- Commercial development of the TGFR system in the medical portfolio could open new revenue sources over time.
Threats
- If asset sales are not completed at sufficient values, the company could breach debt covenants.
- Changes in FCC regulation or delays in approvals could affect the Spectrum transaction.
- Rising steel and labor costs could reduce margins on fixed-price projects.
Risks
- Going concernhigh
The annual report includes substantial doubt about the company's ability to continue as a going concern, linked to debt maturities.
- Change-of-control clauseshigh
A sale of DBMG could trigger clauses that accelerate debt maturity and may cause cross-default events.
- Dependence on distributionsmedium
The company depends on payments from subsidiaries, which contracts and legislation can limit.
- Regulatory approvals for Spectrummedium
The Spectrum transaction depends on FCC approvals and the expiry of antitrust waiting periods.
- Volatility in construction projectsmedium
Projects can be delayed or cancelled, which may create large swings from quarter to quarter.
Investment thesis
What would need to be true (bull case)
- If asset sales close at good values, the company could reduce debt and focus resources on its remaining segments.
- Strong DBMG backlog growth and margin improvement in the second quarter of 2026 suggest solid operating momentum.
- The medical portfolio and the TGFR system could become a source of value if clinical adoption expands.
What would break the thesis
- Doubts about going concern and near-term debt maturities could force sales at unfavourable values.
- If transactions face delays or fail to close, debt could become a major problem.
- Revenue in Life Sciences and Spectrum is small and fell in the second quarter of 2026, limiting diversification.
What to watch
- Completion of the DBMG sale and the outcome of the sales process2026
- Completion of the Spectrum merger with CONX and FCC approvalsby 29 November 2026
- DBMG backlog and quarterly margin trendsQ3 2026
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
The business
INNOVATE is a holding company that owns several subsidiaries, grouped into the Infrastructure, Life Sciences, Spectrum and Other segments. Most of the activity is carried out by DBM Global, an integrated construction and structural steel services company headquartered in Phoenix, Arizona 1. According to the annual report, the company has commenced a sales process for DBMG and for the Spectrum segment, as its debt milestones were not met 1.
Total revenue for fiscal 2025 was 1,210.3 million USD across DBMG's business units, with Schuff Steel the largest contributor 1. The company had 3,587 full-time employees at the end of 2025 1.
The Life Sciences segment, Pansend, supports healthcare and biotechnology product development through stakes in MediBeacon and R2 Technologies, while Spectrum operates over-the-air broadcasting stations 13.
Segments
Market context
DBMG operates in a highly fragmented North American structural steel construction market, where much demand comes from commercial, industrial and infrastructure projects. The company says its scale is an advantage against many small firms, and its project pipeline is about 10.6 billion USD 1. Activity depends on commercial and industrial construction levels, interest rates and financing availability 1.
In the second quarter of 2026 the company reported that demand from technology, healthcare, AI infrastructure and advanced manufacturing supported backlog growth to 2.7 billion USD adjusted 3. If this demand holds, the contract portfolio could support revenue in coming periods.
Trends
- Infrastructure and data center demandtailwind
Demand for industrial construction and data centers supported DBMG revenue growth in 2026, according to the company's release 3.
- Cost of financing and debtheadwind
High interest rates and near-term debt maturities could limit financing options and reduce flexibility in negotiating sales.
- Labor and material costsheadwind
Construction companies are exposed to labor and steel costs, including import tariffs, factors that could affect margins on fixed-price projects.
- Complex project consolidationmixed
Large, complex projects where DBMG faces fewer competitors could support better margins if execution remains strong.
Competitive position
The company says it competes with many small firms in construction, and the market is fragmented; for acquisitions it competes with strategic investors and private equity firms 1. Competition for DBMG contracts is intense, but the company states it can take a stronger position on complex negotiated projects 1.
According to the report, the company's financial resources are relatively limited compared with many competitors, which could reduce its ability to pursue acquisition strategies competitively 1.
- Private equity funds and strategic investors
Compete with the company for acquisitions of assets and businesses, which could raise prices for targets.
- Small structural steel fabrication firms
The fragmented market includes many regional players in fabrication and erection.
- Subcontractors and general contracting firms
They can perform similar work and compete for smaller projects.
- Over-the-air broadcasting operators
Competition in the Spectrum market is intense, according to the annual report.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
- How The Airline That Invented Premium Economy Continues To Innovate In Luxury ServiceSimple Flying · 12 Sept 2026 · EN
- Could IES Holdings (IESC) Win Big While INNOVATE (VATE) Bets its Future on Debt Reduction?Yahoo Finance — News · 29 Aug 2026 · EN
- Build at Scale, Innovate at the Edge, Close the Feedback Loop Fast: Transforming Acquisition for the Drone AgeModern War Institute (West Point) · 20 Jul 2026 · RO
- US must innovate faster to counter China’s tech rise, lawmakers toldSouth China Morning Post — China · 30 Jun 2026 · RO
- US must learn lessons from Ukraine, innovate faster and cheaper: Anduril presidentDefense News (US, EN) · 08 Jun 2026 · RO
- Japan’s nuclear fusion startups innovate beyond energyNikkei Asia · 19 May 2026 · RO
The latest news item in our archive is from 12 Sept 2026; the newest SEC filing is from 09 Oct 2026. The press archive comes from the RSS feeds we follow and does not necessarily cover the latest event — the filings alongside do.
SEC filings
- Current report09 Oct 2026Material agreement · Financial statements and exhibits
- Current report05 Oct 2026Material agreement · Termination of a material agreement · Acquisition or disposition of assets · Departure or appointment of officers · Regulation FD disclosure · Financial statements and exhibits
- Current report02 Sept 2026Material agreement · Termination of a material agreement · Acquisition or disposition of assets · Regulation FD disclosure · Financial statements and exhibits
- Current report18 Aug 2026Other events · Financial statements and exhibits
- Current report10 Aug 2026Material agreement · Regulation FD disclosure · Financial statements and exhibits
- Quarterly report06 Aug 2026
- Current report06 Aug 2026Results of operations · Regulation FD disclosure · Financial statements and exhibits
- Current report03 Aug 2026Material agreement · Financial statements and exhibits
- Current report08 Jul 2026Other events
- Current report11 Jun 2026Shareholder vote · Financial statements and exhibits
Sources
- [1] Form 10-K, fiscal year ended 2025-12-31 · SEC / INNOVATE Corp. · 26 Mar 2026
- [2] Form 10-Q, quarter ended 2026-06-30 · SEC / INNOVATE Corp. · 06 Aug 2026
- [3] Form 8-K, results release (exhibit 99.1) · SEC / INNOVATE Corp. · 06 Aug 2026
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.